SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Germany flag Germany · Delayed Price · Currency is EUR
14.10
+0.18 (1.29%)
Last updated: Apr 14, 2026, 9:19 AM CET
Market Cap2.10B -42.0%
Revenue (ttm)995.03M +4.1%
Net Income149.95M +11.1%
EPS0.99 +10.0%
Shares Out150.61M
PE Ratio14.07
Forward PE14.32
Dividend0.18 (1.29%)
Ex-Dividend DateFeb 4, 2026
Volume3,350
Average Volume68,850
Open13.98
Previous Close13.92
Day's Range13.86 - 14.14
52-Week Range12.62 - 30.25
Beta0.79
RSI49.96
Earnings DateMay 13, 2026

About ETR:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Sector Healthcare
Founded 1884
Employees 4,829
Stock Exchange Deutsche Börse Xetra
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In fiscal year 2025, ETR:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements